Rosen Law seeks lead plaintiff in PROCEPT BioRobotics securities lawsuit
Rosen Law Firm says a class action has been filed against PROCEPT BioRobotics and that investors who bought shares during the stated class period may apply to lead the case by Sept. 22, 2026.
Rosen Law Firm said Thursday that investors who bought PROCEPT BioRobotics Corp. common stock during the stated class period may join a securities fraud class action. The lead-plaintiff deadline is Sept. 22, 2026.
In a notice published on PR Newswire on Aug. 21, 2026, Rosen said the class period runs from Feb. 28, 2024, through Feb. 25, 2026, inclusive, for buyers of PROCEPT BioRobotics Corporation common stock on Nasdaq under the ticker PRCT.
The notice says the case has already been filed and that no class has been certified. It also says the complaint alleges that PROCEPT and certain defendants made materially false or misleading statements or omitted material facts.
Those allegations include an extensive discount program that allegedly encouraged bulk orders above procedure demand, inflated U.S. handpiece unit sales and revenues, customer orders that exceeded underlying procedure demand, and field inventory that grew to more than 10,000 excess units by the end of the class period.
The notice also says the complaint alleges handpiece sales and field-system utilization were overstated, that the company failed to disclose significant operational and financial risks, and that PROCEPT could not meet its stated 2025 handpiece sales and revenue guidance. The notice says investors suffered damages when the true details reached the market.
Rosen’s notice said investors may be eligible for compensation without out-of-pocket fees through a contingency fee arrangement. It also said investors can seek to join the case through the firm’s website or by contacting Phillip Kim, Esq., by phone or email.
The court has not certified a class, and the allegations remain the plaintiffs’ claims as described in the filing notice.
Investors in the stated class period who want to seek appointment as lead plaintiff must act before the Sept. 22, 2026, deadline, according to the notice.
Sources
Editorial note: This article was prepared with AI assistance and includes source attribution for reader review.
Comments ()